Ultragenyx Pharmaceutical Inc (RARE)
41.90
-0.71
(-1.67%)
USD |
NASDAQ |
May 17, 16:00
41.90
0.00 (0.00%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Stock Buybacks (Quarterly)
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -326.46M |
| September 30, 2023 | -24.79M |
| June 30, 2023 | -28.51M |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -435.56M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | -20.39M |
| March 31, 2020 | -55.27M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -5.523M |
| March 31, 2019 | -349.72M |
| December 31, 2018 | -10.43M |
| September 30, 2018 | -15.84M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.019M |
| March 31, 2018 | -282.78M |
| December 31, 2017 | -64.34M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | -0.025M |
| March 31, 2017 | -67.59M |
| December 31, 2016 | -45.79M |
| September 30, 2016 | -33.70M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.022M |
| September 30, 2015 | -283.12M |
| June 30, 2015 | -2.595M |
| March 31, 2015 | -175.44M |
| December 31, 2014 | 0.324M |
| September 30, 2014 | -60.51M |
| June 30, 2014 | -0.01M |
| March 31, 2014 | -128.38M |
| December 31, 2013 | -0.038M |
| September 30, 2013 | -0.076M |
| June 30, 2013 | -0.056M |
| March 31, 2013 | -0.001M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-435.56M
Minimum
Dec 2020
--
Maximum
Sep 2019
-68.96M
Average
-5.523M
Median
Jun 2019
Stock Buybacks (Quarterly) Benchmarks
| Insulet Corp | -- |
| Sarepta Therapeutics Inc | -- |
| FibroGen Inc | 0.00 |
| Apellis Pharmaceuticals Inc | -98.76M |
| Amylyx Pharmaceuticals Inc | -- |